Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study
Emery, P, Bingham, C O, Burmester, G R, Bykerk, V P, Furst, D E, Mariette, X, van der Heijde, D, van Vollenhoven, R, Arendt, C, Mountian, I, Purcaru, O, Tatla, D, VanLunen, B, Weinblatt, M E
Published in Annals of the rheumatic diseases (01.01.2017)
Published in Annals of the rheumatic diseases (01.01.2017)
Get full text
Journal Article
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group
Avouac, J, Fransen, J, Walker, UA, Riccieri, V, Smith, V, Muller, C, Miniati, I, Tarner, IH, Randone, S Bellando, Cutolo, M, Allanore, Y, Distler, O, Valentini, G, Czirjak, L, Müller-Ladner, U, Furst, DE, Tyndall, A, Matucci-Cerinic, M
Published in Annals of the rheumatic diseases (01.03.2011)
Published in Annals of the rheumatic diseases (01.03.2011)
Get full text
Journal Article
Conference Proceeding
Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study
Weinblatt, M E, Keystone, E C, Furst, D E, Kavanaugh, A F, Chartash, E K, Segurado, O G
Published in Annals of the rheumatic diseases (01.06.2006)
Published in Annals of the rheumatic diseases (01.06.2006)
Get full text
Journal Article
Patterns and predictors of change in outcome measures in clinical trials in scleroderma: An individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis
Merkel, P. A., Silliman, N. P., Clements, P. J., Denton, C. P., Furst, D. E., Mayes, M. D., Pope, J. E., Polisson, R. P., Streisand, J. B., Seibold, J. R.
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.10.2012)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.10.2012)
Get full text
Journal Article
Model‐Informed Development and Registration of a Once‐Daily Regimen of Extended‐Release Tofacitinib
Lamba, M, Hutmacher, MM, Furst, DE, Dikranian, A, Dowty, ME, Conrado, D, Stock, T, Nduaka, C, Cook, J, Krishnaswami, S
Published in Clinical pharmacology and therapeutics (01.06.2017)
Published in Clinical pharmacology and therapeutics (01.06.2017)
Get full text
Journal Article
Infliximab in active early rheumatoid arthritis
Breedveld, F C, Emery, P, Keystone, E, Patel, K, Furst, D E, Kalden, J R, St Clair, E W, Weisman, M, Smolen, J, Lipsky, P E, Maini, R N
Published in Annals of the rheumatic diseases (01.02.2004)
Published in Annals of the rheumatic diseases (01.02.2004)
Get full text
Journal Article
Systemic sclerosis and bilateral lung transplantation: a single centre experience
SAGGAR, R, KHANNA, D, SHAPIRO, S, HUNTER, C, GREGSON, A, FISHBEIN, M. C, LYNCH, J. P, ROSS, D. J, FURST, D. E, BELPERIO, J. A, PARK, G. S, WEIGT, S. S, KUBAK, B, ARDEHALI, A, DERHOVANESSIAN, A, CLEMENTS, P. J
Published in The European respiratory journal (01.10.2010)
Published in The European respiratory journal (01.10.2010)
Get full text
Journal Article
Remodeling of the HDL proteome with treatment response to abatacept or adalimumab in the AMPLE trial of patients with rheumatoid arthritis
Charles-Schoeman, C., Gugiu, G.B., Ge, H., Shahbazian, A., Lee, Y.Y., Wang, X., Furst, D.E., Ranganath, V.K., Maldonado, M., Lee, Terry, Reddy, S.T.
Published in Atherosclerosis (01.08.2018)
Published in Atherosclerosis (01.08.2018)
Get full text
Journal Article
Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005
Furst, D E, Breedveld, F C, Kalden, J R, Smolen, J S, Burmester, G R, Bijlsma, J W J, Dougados, M, Emery, P, Keystone, E C, Klareskog, L, Mease, P J
Published in Annals of the rheumatic diseases (01.11.2005)
Published in Annals of the rheumatic diseases (01.11.2005)
Get full text
Journal Article
Conference Proceeding
Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test
Buch, M H, Denton, C P, Furst, D E, Guillevin, L, Rubin, L J, Wells, A U, Matucci-Cerinic, M, Riemekasten, G, Emery, P, Chadha-Boreham, H, Charef, P, Roux, S, Black, C M, Seibold, J R
Published in Annals of the rheumatic diseases (01.02.2007)
Published in Annals of the rheumatic diseases (01.02.2007)
Get full text
Journal Article
Minimally important difference in diffuse systemic sclerosis: results from the d-penicillamine study
Khanna, D, Furst, D E, Hays, R D, Park, G S, Wong, W K, Seibold, J R, Mayes, M D, White, B, Wigley, F F, Weisman, M, Barr, W, Moreland, L, Medsger, T A, Steen, V D, Martin, R W, Collier, D, Weinstein, A, Lally, E V, Varga, J, Weiner, S R, Andrews, B, Abeles, M, Clements, P J
Published in Annals of the rheumatic diseases (01.10.2006)
Published in Annals of the rheumatic diseases (01.10.2006)
Get full text
Journal Article
Development of a provisional core set of response measures for clinical trials of systemic sclerosis
Khanna, D, Lovell, D J, Giannini, E, Clements, P J, Merkel, P A, Seibold, J R, Matucci-Cerinic, M, Denton, C P, Mayes, M D, Steen, V D, Varga, J, Furst, D E
Published in Annals of the rheumatic diseases (01.05.2008)
Published in Annals of the rheumatic diseases (01.05.2008)
Get full text
Journal Article
Incidence and prevalence of adult systemic lupus erythematosus in a large US managed-care population
Furst, DE, Clarke, AE, Fernandes, AW, Bancroft, T, Greth, W, Iorga, SR
Published in Lupus (01.01.2013)
Published in Lupus (01.01.2013)
Get full text
Journal Article
There is a need for new systemic sclerosis subset criteria. A content analytic approach
Johnson, SR, Soowamber, ML, Fransen, J, Khanna, D, Van Den Hoogen, F, Baron, M, Matucci-Cerinic, M, Denton, CP, Medsger, TA, Carreira, PE, Riemekasten, G, Distler, J, Gabrielli, A, Steen, V, Chung, L, Silver, R, Varga, J, Müller-Ladner, U, Vonk, MC, Walker, UA, Wollheim, FA, Herrick, A, Furst, DE, Czirjak, L, Kowal-Bielecka, O, Del Galdo, F, Cutolo, M, Hunzelmann, N, Murray, CD, Foeldvari, I, Mouthon, L, Damjanov, N, Kahaleh, B, Frech, T, Assassi, S, Saketkoo, LA, Pope, JE
Published in Scandinavian journal of rheumatology (02.01.2018)
Published in Scandinavian journal of rheumatology (02.01.2018)
Get full text
Journal Article
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006
Furst, D E, Breedveld, F C, Kalden, J R, Smolen, J S, Burmester, G R, Emery, P, Keystone, E C, Schiff, M H, van Riel, P L C M, Weinblatt, M E, Weisman, M H
Published in Annals of the rheumatic diseases (01.11.2006)
Published in Annals of the rheumatic diseases (01.11.2006)
Get full text
Journal Article
Conference Proceeding
Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents
Furst, D E, Cush, J, Kaufmann, S, Siegel, J, Kurth, R
Published in Annals of the rheumatic diseases (01.11.2002)
Published in Annals of the rheumatic diseases (01.11.2002)
Get full text
Journal Article
Conference Proceeding
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis
van Holten, J, Pavelka, K, Vencovsky, J, Stahl, H, Rozman, B, Genovese, M, Kivitz, A J, Alvaro, J, Nuki, G, Furst, D E, Herrero-Beaumont, G, McInnes, I B, Musikic, P, Tak, P P
Published in Annals of the rheumatic diseases (01.01.2005)
Published in Annals of the rheumatic diseases (01.01.2005)
Get full text
Journal Article